GSK-3 inhibitor CP21R7, Purity ≥98%

Cat. No.: X24-05-ZQ263

GSK-3 inhibitor CP21R7, Purity ≥98%

Synonym: 125314-13-8; CP21; GSK-3 inhibitor

  • CAS Number: 125314-13-8
  • Compound CID: 5327711
Product Size
1 mg; 5 mg; 10 mg
Price
Datasheet
MSDS
Properties
Description
CP21R7, soluble in DMSO and warmed ethanol and insoluble in water, modulates various cellular processes, including glucose metabolism, inflammation, and cell proliferation, with potential applications in treating diseases like diabetes and neurodegenerative disorders. It targets GSK-3β and PKCα.
Molecular Weight
317.34
Molecular Formula
C19H15N3O2
Targets
GSK-3β: 1.8 nM; PKCα: 1900 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 62 mg/mL (195.37 mM); Water: Insoluble; Warmed ethanol: 1 mg/mL (3.15 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
CP21R7 is used to explore its inhibitory effects on GSK-3 in biomedical research.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.